# Braeburn Pharmaceuticals Inc. – FDA Inspection, Feb 8, 2018

Source: https://www.keypedia.com/records/fda_inspections/braeburn-pharmaceuticals-inc/c22b2ae9-da18-413a-b9fd-d96e3f307e35
Source feed: FDA_Inspections

> FDA inspection 1042533 of Braeburn Pharmaceuticals Inc., February 08, 2018. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 314. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1042533
- Company Name: Braeburn Pharmaceuticals Inc.
- Inspection Date: 2018-02-08
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Postmarket Surv. and Epidemiology
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1035711 - 2017-11-28

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/michelle-a-marsh/0aef2015-621a-4948-bb7e-2be3e338a8c8)
- [Issuing Officer](https://www.keypedia.com/people/shirley-s-wen/eafbc8e5-a0ac-443a-adaf-ced505f77842)

Company: https://www.keypedia.com/companies/braeburn-pharmaceuticals-inc/9e6d4a27-2411-4059-a693-b9e3e42d3022

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c